Basilea Pharmaceutica AG (BSLN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.305x

Based on the latest financial reports, Basilea Pharmaceutica AG (BSLN) has a cash flow conversion efficiency ratio of 0.305x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF39.03 Million ≈ $49.35 Million USD) by net assets (CHF127.94 Million ≈ $161.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Basilea Pharmaceutica AG fund operations to measure how many days the company can operate on defensive assets alone.

Basilea Pharmaceutica AG - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Basilea Pharmaceutica AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Basilea Pharmaceutica AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Basilea Pharmaceutica AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hunan Huakai Cultural and Creative Co Ltd SHE:300592	0.048x
Lotte Reit Co Ltd KO:330590	N/A
Lander Sports Development Co Ltd SHE:000558	-0.135x
Cita Mineral Investindo Tbk PT JK:CITA	0.043x
Placoplatre SA PA:MLPLC	N/A
Cryoport Inc NASDAQ:CYRX	0.008x
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	-0.008x
SunCoke Energy Inc NYSE:SXC	0.013x

Annual Cash Flow Conversion Efficiency for Basilea Pharmaceutica AG (2002–2025)

The table below shows the annual cash flow conversion efficiency of Basilea Pharmaceutica AG from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Basilea Pharmaceutica AG market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF127.94 Million ≈ $161.75 Million	CHF62.09 Million ≈ $78.50 Million	0.485x	-47.14%
2024-12-31	CHF81.00 Million ≈ $102.40 Million	CHF74.36 Million ≈ $94.01 Million	0.918x	+164.47%
2023-12-31	CHF-10.00 Million ≈ $-12.65 Million	CHF14.24 Million ≈ $18.01 Million	-1.424x	-318.08%
2022-12-31	CHF-20.71 Million ≈ $-26.19 Million	CHF7.06 Million ≈ $8.92 Million	-0.341x	-162.35%
2021-12-31	CHF-58.61 Million ≈ $-74.10 Million	CHF-32.02 Million ≈ $-40.48 Million	0.546x	+2.99%
2020-12-31	CHF-102.05 Million ≈ $-129.01 Million	CHF-54.13 Million ≈ $-68.44 Million	0.530x	-22.75%
2019-12-31	CHF-92.96 Million ≈ $-117.53 Million	CHF-63.84 Million ≈ $-80.71 Million	0.687x	-42.19%
2018-12-31	CHF-66.69 Million ≈ $-84.31 Million	CHF-79.21 Million ≈ $-100.14 Million	1.188x	+358.87%
2017-12-31	CHF-41.44 Million ≈ $-52.39 Million	CHF19.01 Million ≈ $24.04 Million	-0.459x	-121.41%
2016-12-31	CHF-35.00 Million ≈ $-44.25 Million	CHF-75.00 Million ≈ $-94.82 Million	2.143x	+146.97%
2015-12-31	CHF14.86 Million ≈ $18.78 Million	CHF-67.78 Million ≈ $-85.69 Million	-4.562x	-269.86%
2014-12-31	CHF57.93 Million ≈ $73.24 Million	CHF-71.46 Million ≈ $-90.35 Million	-1.234x	-47.01%
2013-12-31	CHF70.87 Million ≈ $89.60 Million	CHF-59.47 Million ≈ $-75.19 Million	-0.839x	-159.74%
2012-12-31	CHF105.50 Million ≈ $133.38 Million	CHF148.17 Million ≈ $187.33 Million	1.404x	+361.31%
2011-12-31	CHF153.27 Million ≈ $193.77 Million	CHF-82.38 Million ≈ $-104.15 Million	-0.537x	-205.96%
2010-12-31	CHF210.24 Million ≈ $265.80 Million	CHF106.64 Million ≈ $134.82 Million	0.507x	+143.29%
2009-12-31	CHF97.73 Million ≈ $123.56 Million	CHF-114.51 Million ≈ $-144.77 Million	-1.172x	-84.04%
2008-12-31	CHF199.74 Million ≈ $252.53 Million	CHF-127.17 Million ≈ $-160.77 Million	-0.637x	-170.10%
2007-12-31	CHF335.10 Million ≈ $423.66 Million	CHF-78.99 Million ≈ $-99.86 Million	-0.236x	+63.47%
2006-12-31	CHF112.31 Million ≈ $141.99 Million	CHF-72.47 Million ≈ $-91.62 Million	-0.645x	-415.05%
2005-12-31	CHF167.87 Million ≈ $212.23 Million	CHF34.38 Million ≈ $43.47 Million	0.205x	+166.86%
2004-12-31	CHF209.60 Million ≈ $264.99 Million	CHF-64.20 Million ≈ $-81.17 Million	-0.306x	+47.24%
2003-12-31	CHF90.29 Million ≈ $114.15 Million	CHF-52.42 Million ≈ $-66.28 Million	-0.581x	-13.63%
2002-12-31	CHF125.38 Million ≈ $158.51 Million	CHF-64.07 Million ≈ $-81.00 Million	-0.511x	--

About Basilea Pharmaceutica AG

SW:BSLN Switzerland Biotechnology

Market Cap

$773.53 Million

CHF611.84 Million CHF

Market Cap Rank

#10883 Global

#132 in Switzerland

Share Price

CHF49.85

Change (1 day)

+0.50%

52-Week Range

CHF44.90 - CHF58.60

All Time High

CHF108.80